Latest / Diabetes Connections | Type 1 Diabetes
SAB Bio's Safeguard Study: A New Way to Approach Type 1 Diabetes Delay and Prevention
What's next in the attempt to change the course of type 1 diabetes? SAB Bio says they're looking to redefine what it means to get a type 1 diabetes diagnosis. They're trialing a drug right now preserve the patient's ability to make their own insulin.. and maybe even allow repeat dosing. I'm talking to Dr. Michael Haller from the University of Florida and Sam Reich the CEO of SAB Bio about what makes this different and what their big hopes are.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
Announcing Community…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.